Popular search terms:
Search Results
17 results found-
CSL Behring is a global biotech company leading the way to deliver innovative therapies for rare and serious diseases.
https://www.cslbehring.com.au/our-company -
CSL Behring provides protein-based therapies for bleeding disorders, critical care, pulmonary disease, and other rare illnesses.
https://www.cslbehring.com.au/products -
This included a variety of communication methods such as podcasts, print media and animations for people living with haemophilia.
https://www.cslbehring.com.au/-/media/cslb-australia/documents/csl-behring-2024-health-consumer-organisation-support-pdf.pdf -
Paul Perreault is the Chief Executive Officer (CEO) and Managing Director of CSL Limited.
https://www.cslbehring.com.au/our-company/global-leadership-team/paul-perreault -
Press and News Releases from CSL Behring Australia
https://www.cslbehring.com.au/news/2025/20251605-csl-behring-broadmeadows-named-2025-international-society -
August 2023 Silver sponsorship of the 21st Conference on Haemophilia, VWD and Rare Bleeding Disorders.
https://www.cslbehring.com.au/-/media/cslb-australia/documents/transparency-reports/csl-behring-third-party-meeting-and-symposia-sponsorship-report-may-2023-to-oct-2023.pdf -
CSL Behring Marks World Haemophilia Day by Shipping Bleeding Disorders Medicines to the World Federation of Haemophilia
https://www.cslbehring.com.au/news/2018/life-saving-medicines-donated-for-patients-in-the-developing-world -
Support was provided to adapt and re-purpose content from a range of sources to provide education and peer support resources for haemophilia communities Haemophilia Foundation Australia across Australia.
https://www.cslbehring.com.au/-/media/cslb-australia/documents/transparency-reports/csl-behring-2022-health-consumer-organisation-support-pdf.pdf